Nuvalent, Inc. Class A Common Stock (NUVL) is a publicly traded Healthcare sector company. As of July 15, 2026, NUVL trades at $123.96 with a market cap of $9.81B and a P/E ratio of -21.19. NUVL moved +0.02% today. Year to date, NUVL is +23.23%; over the trailing twelve months it is +46.54%. Its 52-week range spans $55.54 to $123.99. Analyst consensus is neutral with an average price target of $125.18. Rallies surfaces NUVL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
18 analysts cover NUVL: 0 strong buy, 1 buy, 17 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $125.18.
| Metric | Value |
|---|---|
| Price | $123.96 |
| Market Cap | $9.81B |
| P/E Ratio | -21.19 |
| EPS | $-5.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $123.99 |
| 52-Week Low | $55.54 |
| Volume | 939.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-425.38M |
| Gross Margin | 0.00% |
18 analysts cover NUVL: 0 strong buy, 1 buy, 17 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $125.18.